Tower Research Capital (TRC)’s Rentokil RTO Stock Holding History
Bought
Maintained
Sold
Other funds holding RTO
GCM
RRAM
SCM
SL
Tower Research Capital (TRC)'s RTO Position: Q1 2026 in Review
Tower Research Capital (TRC) reduced its Rentokil (RTO) stake by 100% in Q1 2026, selling an estimated $1.09M and leaving 82 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #4454.
Tower Research Capital (TRC) first reported a position in RTO in Q4 2022 and has held it in 14 quarters since. The position peaked at $7.05M in Q2 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.
- Tower Research Capital (TRC) held 82 shares of Rentokil worth $2.58K as of Q1 2026.
- Tower Research Capital (TRC) sold 34,583 Rentokil shares in Q1 2026, an estimated $1.09M.
- Rentokil made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4454 holding.
- Tower Research Capital (TRC) first reported a position in Rentokil in Q4 2022 and has held it in 14 quarters since.
- Tower Research Capital (TRC)'s Rentokil position peaked at $7.05M in Q2 2025.
- 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.